Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,926,309
-
Share change
-
+71,153
-
Total reported value
-
$39,107,660
-
Price per share
-
$10.00
-
Number of holders
-
26
-
Value change
-
+$712,040
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q4 2014
As of 31 Dec 2014,
ARGOS THERAPEUTICS INC - COM (ARGS) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,926,309 shares.
The largest 10 holders included
WASATCH ADVISORS INC, AWM Investment Company, Inc., WALL STREET ASSOCIATES, CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, ALTRINSIC GLOBAL ADVISORS LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., Pinnacle Summer Investments, Inc., CREDIT SUISSE AG/, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.